These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8382726)

  • 1. Microencapsulated human parainfluenza virus induces a protective immune response.
    Ray R; Novak M; Duncan JD; Matsuoka Y; Compans RW
    J Infect Dis; 1993 Mar; 167(3):752-5. PubMed ID: 8382726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2017 Dec; 35(51):7139-7146. PubMed ID: 29153777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats.
    Ambrose MW; Wyde PR; Ewasyshyn M; Bonneau AM; Caplan B; Meyer HL; Klein M
    Vaccine; 1991 Jul; 9(7):505-11. PubMed ID: 1654680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.
    Ray R; Glaze BJ; Compans RW
    J Virol; 1988 Mar; 62(3):783-7. PubMed ID: 2828674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters.
    Rydbeck R; Löve A; Norrby E
    J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined oral/nasal immunization protects mice from Sendai virus infection.
    Nedrud JG; Liang XP; Hague N; Lamm ME
    J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses of dairy cattle to parainfluenza-3 virus in intranasal infectious bovine rhinotracheitis-parainfluenza-3 virus vaccines.
    Burroughs AL; Morrill JL; Bostwick JL; Ridley RK; Fryer HC
    Can J Comp Med; 1982 Jul; 46(3):264-6. PubMed ID: 6290012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.
    Durbin AP; Wyatt LS; Siew J; Moss B; Murphy BR
    Vaccine; 1998 Aug; 16(13):1324-30. PubMed ID: 9682397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine.
    Ray R; Brown VE; Compans RW
    J Infect Dis; 1985 Dec; 152(6):1219-30. PubMed ID: 2999259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3.
    Ray R; Glaze BJ; Moldoveanu Z; Compans RW
    J Infect Dis; 1988 Apr; 157(4):648-54. PubMed ID: 2831281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine.
    Ewasyshyn M; Caplan B; Bonneau AM; Scollard N; Graham S; Usman S; Klein M
    Vaccine; 1992; 10(6):412-20. PubMed ID: 1317984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parainfluenza virus induces a type-specific protective immune response.
    Ray R; Matsuoka Y; Burnett TL; Glaze BJ; Compans RW
    J Infect Dis; 1990 Sep; 162(3):746-9. PubMed ID: 2167342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of cotton rats by immunization with the human parainfluenza virus type 3 fusion (F) glycoprotein expressed on the surface of insect cells infected with a recombinant baculovirus.
    Hall SL; Murphy BR; van Wyke Coelingh KL
    Vaccine; 1991 Sep; 9(9):659-67. PubMed ID: 1659054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
    Greer CE; Zhou F; Legg HS; Tang Z; Perri S; Sloan BA; Megede JZ; Uematsu Y; Vajdy M; Polo JM
    Vaccine; 2007 Jan; 25(3):481-9. PubMed ID: 17052811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of the immunoprotective abilities of glycosylated and deglycosylated parainfluenza virus type 3 surface glycoproteins.
    Ewasyshyn M; Bonneau AM; Usman S; Scollard N; Klein M
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2781-5. PubMed ID: 8277287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.
    Spriggs MK; Collins PL; Tierney E; London WT; Murphy BR
    J Virol; 1988 Apr; 62(4):1293-6. PubMed ID: 2831389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.
    Tang RS; Schickli JH; MacPhail M; Fernandes F; Bicha L; Spaete J; Fouchier RA; Osterhaus AD; Spaete R; Haller AA
    J Virol; 2003 Oct; 77(20):10819-28. PubMed ID: 14512532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.